Elanco Animal Health Inc. Stock
There is an upward development for Elanco Animal Health Inc. compared to yesterday, with an increase of €0.14 (1.130%).
Currently there is a rather positive sentiment for Elanco Animal Health Inc. with 6 Buy predictions and 3 Sell predictions.
As a result the target price of 15 € shows a slightly positive potential of 19.27% compared to the current price of 12.58 € for Elanco Animal Health Inc..
Pros and Cons of Elanco Animal Health Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Elanco Animal Health Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc. | 1.130% | 1.436% | -13.053% | 52.068% | -6.982% | -52.309% | - |
| Pfizer Inc. | 0.040% | 8.957% | 2.865% | -25.718% | -0.958% | -21.714% | -26.103% |
| Biogen Inc. | 1.010% | 3.482% | 6.061% | -28.181% | -14.292% | -11.437% | -2.344% |
| AbbVie Inc. | 1.590% | 1.956% | -7.037% | 12.726% | 8.622% | 60.055% | 116.534% |
Comments
Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $12.50 to $14.00. They now have a "sell" rating on the stock.
Show more
Ratings data for ELAN provided by MarketBeat
Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at Morgan Stanley from $16.00 to $17.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ELAN provided by MarketBeat
Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at Barclays PLC from $18.00 to $19.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ELAN provided by MarketBeat